Skip to main content
Gland Pharma Limited logo

Gland Pharma Limited — Investor Relations & Filings

Ticker · GLAND ISIN · INE068V01023 LEI · 335800JJVDY5R6KF5K34 BSE.NS Manufacturing
Open in API
Filings indexed 680 across all filing types
Latest filing 2021-01-29 Regulatory Filings
Country IN India
Listing BSE.NS GLAND

About Gland Pharma Limited

https://glandpharma.com

Gland Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) focused on injectable formulations. The company operates primarily through a business-to-business (B2B) model, providing development and manufacturing services for a diverse range of sterile injectables. Its portfolio encompasses complex generics across various therapeutic areas, including oncology, ophthalmology, anti-infectives, and orthopedics. Gland Pharma maintains a vertically integrated supply chain, ensuring control over critical raw materials and active pharmaceutical ingredients. The company serves a global market, with a significant presence in regulated regions such as the United States, Europe, Canada, and Australia. Its manufacturing facilities adhere to international quality standards and hold approvals from major regulatory bodies. Key strengths include expertise in niche segments like heparin and enoxaparin, alongside a robust pipeline of complex delivery systems.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated January 29, 2021, addressed to stock exchanges in India, providing a schedule of upcoming analyst and institutional investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which mandates disclosure of material events. The content is an announcement of scheduled meetings rather than a detailed financial report, earnings release, or presentation. The document length is only 1595 characters, indicating it is brief and informational. There is no financial data, no detailed report, no voting results, or management changes. This fits the category of an Investor Presentation announcement or meeting schedule notice. However, since it is only a schedule notice and not the presentation itself, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories. Confidence is high due to clear regulatory reference and document content.
2021-01-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated January 28, 2021, addressed to stock exchanges, informing about the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which governs disclosures related to investor relations activities. The content is a meeting schedule announcement rather than a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or voting results. The document length is only 1529 characters, indicating it is a brief announcement. Therefore, it fits best under the category of Investor Presentation (IP) or a related category. However, since it is specifically about scheduling analyst/investor meetings and not the presentation itself, it is best classified as Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-01-28 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of unaudited financial results for the quarter and nine months ended December 31, 2020. It includes financial data such as revenue, profit before tax, profit for the period, comprehensive income, equity share capital, and earnings per share. The document mentions that these results were reviewed by the Audit Committee and approved by the Board of Directors, and subject to limited review by statutory auditors. It is explicitly described as 'Unaudited Financial Results' and contains substantive financial data and analysis for a period shorter than a full fiscal year (quarter and nine months). This matches the definition of an Interim / Quarterly Report (IR). The document is not merely an announcement of a report or a certification, but contains actual financial results and notes. Therefore, the correct classification is IR with high confidence.
2021-01-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated January 23, 2021, addressed to stock exchanges, informing about the schedule of Analyst/Institutional Investor Meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which mandates disclosure of material events. The content is a meeting schedule announcement, not a financial report, earnings release, or detailed investor presentation. The document length is only 1622 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2021-01-23 English
Monitoring Agency Report
Regulatory Filings Classification · 95% confidence The document is titled 'Report of the Monitoring Agency' and is dated January 22, 2021. It references SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and relates to the utilization of proceeds from an IPO for the quarter ended December 31, 2020. The report is issued by Axis Bank Limited as the Monitoring Agency and provides detailed information on the use of IPO proceeds, including cost of objects, progress, and deployment of unutilized proceeds. This type of report is a regulatory compliance document monitoring the use of capital raised through an IPO, not a financial report like an annual or quarterly report. It is not a certification or a brief announcement but a substantive monitoring report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-01-22 English
ESOP/ESOS/ESPS
Regulatory Filings Classification · 90% confidence The document text is extremely short (308 characters) and contains only header information related to stock exchange listing departments and codes. There is no substantive content, financial data, or report details. It appears to be a brief regulatory or listing-related notice without any report or announcement content. Given the lack of detailed information and the nature of the text, the best fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories.
2021-01-22 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.